Records containing: Venous Thromboembolism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-07-01Reversion of the Anticoagulant Effect of the New Antithrombotic Agents Anti-Xa and Anti IIa by Specific and Non-specific Haemostatic Drugs,: an Ex-Vivo Study in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2011-06-03Prospective Study Assessing the Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism
-
CLINICAL_TRIALS study record update · 2011-06-01Multi-centered Discharge Alert to Prevent DVT and PE at Hospital Discharge
-
CLINICAL_TRIALS study record update · 2011-02-25Spreading and Improving DVT Prophylaxis at Mayo Clinic (DVT-P-Spread)
-
CLINICAL_TRIALS study record update · 2011-01-11A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-01-06YM150 Long Term Study - Long-term Study in Patients With a History of Venous Thromboembolism
-
CLINICAL_TRIALS study record update · 2010-12-17A Phase III Randomised, Parallel Group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Orally Administered 220 mg Dabigatran Etexilate Capsules (110 mg Administered on the Day of Surgery Followed by 220 mg Once Daily) Compared to Subcutaneous 40 mg Enoxaparin Once Daily for 28-35 Days, in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip Arthroplasty Surgery. (RE-NOVATE II)
-
CLINICAL_TRIALS study record update · 2010-12-16BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
-
CLINICAL_TRIALS study record update · 2010-11-16in Typical Community Practice Settings
-
CLINICAL_TRIALS study record update · 2010-10-27NON CLINICAL INFERIORITY OF HEPARIN SODIUM PRODUCED BY HIPOLABOR FARMACEUTICA LTDA COMPARED TO THE HEPARIN SODIUM PRODUCED BY APP PHARMACEUTICALS IN VENOUS THROMBOEMBOLISM PROPHYLAXIS, IN SURGICAL PATIENTS WITH MEDIUM RISK FOR DEVELOPMENT OF THROMBOEMBOLISM.
-
CLINICAL_TRIALS study record update · 2010-08-06Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005
-
CLINICAL_TRIALS study record update · 2010-06-16A Multi-center, Open Label Study With YM150, a Direct Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
-
CLINICAL_TRIALS study record update · 2010-06-16A Randomized, Open Label Parallel Group Mechanical Prophylaxis Controlled Comparison Study With YM150, a Direct Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
-
CLINICAL_TRIALS study record update · 2010-06-16YM150 Phase III Study - An Open-label, Multi-center Study in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities
-
CLINICAL_TRIALS study record update · 2010-06-16Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Knee Replacement Surgery -
-
CLINICAL_TRIALS study record update · 2010-06-09Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery
-
CLINICAL_TRIALS study record update · 2010-04-28Multicentric, Rand., D-b, Pbo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of the Thromboprophylaxis With Bemiparin 3,500 IU/d for 28 Days Compared to 8 Days, in Patients Undergoing Oncological Abdominal/ Pelvic Surgery
-
CLINICAL_TRIALS study record update · 2010-04-06Prospective Study of the Cook Celect Filter, Including Permanent and Retrievable Use
-
CLINICAL_TRIALS study record update · 2010-03-29Trousseau Studie, Mortaliteit Door Maligniteit Bij patiënten Met Idiopatische Veneuze Tromboembolie
-
CLINICAL_TRIALS study record update · 2009-12-02Use of OCs Containing Dienogest and Risk of Venous Thromboembolism
-
CLINICAL_TRIALS study record update · 2009-11-25Management of Prothrombin Times Outside the Therapeutic Range in Patients on Warfarin and With Otherwise Stable Levels
-
CLINICAL_TRIALS study record update · 2009-10-02Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients.
-
CLINICAL_TRIALS study record update · 2009-07-13Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database
-
CLINICAL_TRIALS study record update · 2009-07-10Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery
-
CLINICAL_TRIALS study record update · 2009-06-03A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery